The gross margin on Humira is in the neighborhood of 85%, as far as I can tell. It is almost certainly the highest-margin significant product in ABT’s portfolio.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”